Valuation : Treace Medical Concepts, Inc.

Market Cap 313M 269M 253M 231M 433M 29.53B 434M 2.99B 1.16B 15.15B 1.17B 1.15B 48.82B P/E 2026 *
-5.65x
P/E 2027 * -6.21x
Enterprise Value 358M 308M 290M 265M 496M 33.85B 497M 3.43B 1.33B 17.37B 1.35B 1.32B 55.94B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.8x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-1.43%
1 week+3.44%
Current month+2.34%
1 month+1.48%
3 months+30.35%
6 months+227.21%
Current year+96.33%
1 week 4.55
Extreme 4.55
4.93
1 month 4.25
Extreme 4.25
5.2
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.63
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/24/26 A Buy

Chief Executive Officer

11,000 0.0170%
8/9/26 A Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 A Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%+3.44%-32.91%-69.11% 313M
+0.32%+0.15%+15.18%+21.98% 12.69B
-0.98%-2.26%+15.69%+25.94% 6.88B
-2.33%+15.85% - - 6.54B
-2.41%-7.59%+30.36%+20.60% 5.99B
+3.02%+1.31%-17.27%+53.59% 5.21B
+0.51%-1.90%-29.86%-22.51% 3.83B
+1.70%+0.67%+49.75%-19.52% 2.09B
-2.02%-3.00%-7.32%+130.04% 1.72B
+2.63%-1.57%+53.11%-14.27% 1.64B
Average -0.10%+0.75%+8.52%+14.08% 4.69B
Weighted average by Cap. -0.23%+1.06%+11.05%+22.61%

Financials

2026 *2027 *
Net sales 207M 179M 168M 153M 287M 19.59B 288M 1.98B 770M 10.05B 779M 762M 32.38B 222M 191M 180M 164M 307M 20.94B 308M 2.12B 823M 10.74B 833M 814M 34.6B
Net income -55.26M -47.56M -44.74M -40.87M -76.46M -5.22B -76.67M -529M -205M -2.68B -208M -203M -8.62B -51.01M -43.9M -41.3M -37.73M -70.58M -4.82B -70.77M -488M -189M -2.47B -192M -187M -7.96B
Net Debt 45.67M 39.3M 36.97M 33.77M 63.18M 4.31B 63.35M 437M 170M 2.21B 171M 168M 7.13B 86.44M 74.38M 69.98M 63.93M 120M 8.16B 120M 827M 321M 4.19B 325M 318M 13.49B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
04/09/26 $4.810 -1.43% 231,834
03/09/26 $4.880 +3.83% 275,358
02/09/26 $4.700 +2.17% 172,390
01/09/26 $4.600 -2.13% 254,456
31/08/26 $4.700 +1.08% 260,961
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.810USD
Average target price
5.500USD
Spread / Average Target
+14.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock